Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLC

Ruchika Sharma20 Dec 2025 1:30 PM IST

Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT FASPRO (amivantamab and...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

Granules India arm gets 5 USFDA observations for Hyderabad facility

Ruchika Sharma20 Dec 2025 12:38 PM IST

Telangana: Granules India has announced that the U.S. Food and Drug Administration (FDA) has concluded an inspection with five observations...

KGMU Doctor Absconding in Conversion Case, Parents Arrested

Delhi based pharma firm owner caught in drug trafficking case in Jammu

Ruchika Sharma19 Dec 2025 6:12 PM IST

Jammu: In a significant breakthrough against a drug trafficking network, the Anti-Narcotics Task Force (ANTF) of Jammu and Kashmir Police has...

CDSCO Expert Panel Accepts Phase IV Safety Data for Eisai Pharmas Lenvatinib Capsules

Telangana issues advisory on prescription medicines sales in Telangana

Ruchika Sharma19 Dec 2025 4:48 PM IST

Telangana: The Drugs Control Administration, Telangana, has issued an advisory to all retail and wholesale medical shops as well as general...

Surat Chemist Allegedly Manufactured Banned Mephedrone to Repay Forex Losses, Held

Kingpin behind spurious Betnovate-C ointment racket arrested

Ruchika Sharma19 Dec 2025 3:29 PM IST

In the latest development in a major spurious drugs and fake cosmetics case, Delhi Police has arrested the alleged mastermind of the racket, officials...

JnJ Medtech bags USFDA nod for TRUFILL n-BCA Liquid Embolic System for Symptomatic Chronic Subdural Hematoma

Ruchika Sharma19 Dec 2025 12:30 PM IST

Irvine: Johnson & Johnson MedTech has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the...

Biocon Strengthens Control Over Biologics Unit, Issues Shares to Mylan, Other Investors

USFDA issues EIR for Biocon Generics Cranbury facility

Ruchika Sharma19 Dec 2025 11:30 AM IST

Bengaluru: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated...

Lupin signs licensing pact with Gan & Lee Pharma for GLP-1 receptor agonist Bofanglutide

Lupin, Neopharmed sign licensing pact for Gastro brand Plasil in Brazil, Philippines

Ruchika Sharma18 Dec 2025 5:23 PM IST

Plasil is widely acknowledged for its efficacy in treating nausea, vomiting, and motility disorders.

India pharma market expected to hit USD 130 bn by 2030: Commerce Secretary

Ruchika Sharma18 Dec 2025 3:53 PM IST

New Delhi: India's pharmaceutical exports stood at USD 30.47 billion in 2024-25, registering a growth of 9.4 percent over the previous year, supported...

AstraZeneca-Daiichi Sankyo Enhertu gets USFDA Breakthrough Therapy Designation in HER2-positive early breast cancer

AstraZeneca Pharma India wins CDSCO permission to import breast cancer drug Datverzo

Ruchika Sharma18 Dec 2025 3:15 PM IST

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization (CDSCO),...

Amid Debt Pressure, Sun Pharmas Research Arm SPARC Plans 40% Workforce Reduction

Sun Pharma Baska facility gets OAI status from USFDA

Ruchika Sharma18 Dec 2025 2:27 PM IST

Mumbai: Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and Drug Administration...

Alembic Pharma secures USFDA approval for Travoprost Ophthalmic Solution

Alembic Pharma secures USFDA approval for Glaucoma treatment

Ruchika Sharma18 Dec 2025 12:34 PM IST

Vadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok